Over the last few years, BC treatment has advanced significantly, with endocrine treatment, anti-HER2 (human epidermal growth factor receptor 2) antibodies and chemotherapy, which make the therapeutic backbone, depending on the clinical tumor subtype. This evidence concerns the gene ERBB2 and neoplasm.